Action 002581 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shandong Sinobioway Biomedicine Co., Ltd.

Actions

002581

CNE1000012Y5

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 09/05/2024 		Varia. 5j. Varia. 1 janv.
13,69 CNY +0,59% Graphique intraday de Shandong Sinobioway Biomedicine Co., Ltd. -0,80% -6,23%
29/04 Shandong Sinobioway Biomedicine Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
29/04 Shandong Sinobioway Biomedicine Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Sinobioway Biomedicine's Unit to Relocate
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shandong Sinobioway Biomedicine Co., Ltd.(XSEC:002581) added to S&P Global BMI Index
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Sinobioway Biomedicine Taps Builders for Planned Industrial Park
Sinobioway Biomedicine Earmarks 1 Billion Yuan for Pharmaceutical Industrial Park
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Shandong Sinobioway Biomedicine Co., Ltd. Announces Executive Appointments
Shenzhen Yilian Technology Limited Company and Shenzhen Jialian Private Equity Investment Fund Management Co., Ltd. won the auction to acquire 8.67% stake in Shandong Sinobioway Biomedicine Co., Ltd. from Beijing Sinobioway Group Co., Ltd. for CNY 77.85 million.
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Xiamen Hengxing Group Co., Ltd. acquired Shandong Sinobioway Biomedicine Co., Ltd. from Shenzhen Sandao Investment Management Enterprise (Limited Partnership) for CNY 200 million.
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 002581
  4. Actualités Shandong Sinobioway Biomedicine Co., Ltd.
  5. Autres langues